openPR Logo
Press release

Global Pneumococcal Vaccine Market 2020 Analysis May Set New Growth Story, Forecast to 2026

02-02-2021 11:10 AM CET | Health & Medicine

Press release from: Orion Market Research

The global pneumococcal vaccine market is forecast to grow at a CAGR of nearly 4.0% during the forecast period. Increasing individual, governmental, and international organization expenditure on the pneumococcal vaccine to curb the pneumonia is a major factor for the growth of the market in the near future. Few market players have a major market share in the pneumococcal vaccine all across the globe which includes Pfizer Inc., Sanofi SA, and GlaxoSmithKline PLC.

Request a Free Sample of our Global Pneumococcal Vaccine Market: https://www.omrglobal.com/request-sample/pneumococcal-vaccine-market

Pfizer is the market leader in the pneumococcal vaccine market. The company offers the pneumococcal vaccine under the brand name Prevnar 13. It first got the European Union approval in December 2009 and then the US FDA approval in February 2010. In 2019, the company generated $5.8 billion from the sales of Prevnar 13. Out of the total revenue, around $3.2 billion was generated from the US alone.

Merck & Co., Inc. is another major company offering vaccines all across the globe. The company offers Pneumovax 23. The vaccine has generated revenue of $926 million in 2019 as compared to $907 million and $821 million in 2018 and 2017 respectively. GlaxoSmithKline PLC is another major player in the pneumococcal vaccine. The company is offering Synflorix against pneumonia all across the globe except the US. The vaccine has generated revenue of more than $580 million in 2019 compared to more than $430 million in 2018. The company also offers its vaccines to 10 Gavi-eligible countries at a discounted price. The company has pledged to deliver 720 million doses of Synflorix.

However, new players are also entering the market which can end the monopoly of the companies in the global market. For instance, in January 2020, a Chinese company Walvax Biotechnology Co., Ltd. got the pneumococcal 13-valent conjugate vaccine approval from the National Medical Products Administration. It is the first pneumococcal 13-valent conjugate vaccine developed which can affect the revenue of Pfizer Inc. In 2018, about 3.85 million doses of Prevnar 13 were sold in China whereas Walva is planning to produce around 30 million doses in a year. Moreover, in December 2019, India based Serum Institute of India also developed a 10-valent pneumococcal vaccine and got WHO approvals.

However, the major players are also significantly working to develop new products. For instance, Pfizer Inc. is working to develop a vaccine against all 20 serotypes of pneumonia disease. Merck & Co., Inc. is also working on the V114 polyvalent conjugate 15-valent pneumococcal vaccine. Phase 3 of the vaccine was initiated in June 2018 in adults over 50 years and on pediatric were initiated in October 2018. In June 2020, the company got success in two phases 3 trials of the vaccine. Due to multiple activities, a considerable disruption in the revenue of the companies will be witnessed in the near future which are dealing in the pneumococcal vaccine industry.

A full Report of Global Pneumococcal Vaccine Market is Available at: https://www.omrglobal.com/industry-reports/pneumococcal-vaccine-market

Global Pneumococcal Vaccine Market- Segmentation

By Vaccine Type

• Pneumococcal Conjugate Vaccine (PCV13)
• Pneumococcal Polysaccharide Vaccine (PPSV23)
• Others

By Distribution Channel

• Public
• Private

By Type

• Branded
• Generic

By Age Group

• Children
• Adult

Global Pneumococcal Vaccine Market– Segment by Region

North America

• United States
• Canada

Europe

• Germany
• UK
• France
• Spain
• Italy
• Rest of Europe

Asia-Pacific

• China
• Japan
• India
• Rest of Asia-Pacific

Rest of the World

Company Profiles
• Astellas Pharma Inc.
• China National Biotec Group Company Ltd.
• CSL Ltd.
• GlaxoSmithKline PLC
• Merck & Co., Inc.
• Novavax, Inc.
• Pfizer Inc.
• Walvax Biotechnology Co., Ltd.
• SK Bioscience
• Sanofi SA
• Serum Institute of India Pvt. Ltd.
• PnuVax Incorporated

Reasons to Buying From us –
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/pneumococcal-vaccine-market

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Pneumococcal Vaccine Market 2020 Analysis May Set New Growth Story, Forecast to 2026 here

News-ID: 2234692 • Views:

More Releases from Orion Market Research

Hair Accessories Market Poised for Strong Growth Driven by Gen Z Trends and Sustainability Preferences
Hair Accessories Market Poised for Strong Growth Driven by Gen Z Trends and Sust …
Hair accessories market was valued at $23.8 billion in 2024 and is projected to reach $55.2 billion in 2035, growing at a CAGR of 8.2% during the forecast period (2025-2035). Generation Z, with significant disposable income, is transforming the hair accessories category in a major way. Their close connection to trends creates a unique feeling of urgency to self-express through fashion, such as clips, scrunchies, and barrettes. It has become
Railway Management System Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
Railway Management System Market Size Analysis, Competitive Insights, Leading Pl …
Railway System (or Railway Management System) market was valued at approximately USD 28.28 billion, and it is expected to reach about USD 45.19 billion by 2033, growing at a CAGR of around 4.8% from 2024 to 2033. Railway Management System Market Overview The Railway Management System market includes technologies and systems used to plan, monitor, and manage railway operations-everything from traffic and signaling systems to asset and maintenance management, passenger information,
Monocalcium Phosphate Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
Monocalcium Phosphate Market Size Analysis, Competitive Insights, Leading Player …
Monocalcium Phosphate market was valued at about USD 4.2 billion, and it is anticipated to reach around USD 6.9 billion by 2033, growing at a CAGR of approximately 5% from 2023 to 2033. Monocalcium Phosphate Market Overview Monocalcium phosphate (MCP) is a calcium-phosphorus compound widely used in animal feed, fertilizers, and also in food and beverage applications (for example as leavening agent or acidity regulator), due to its solubility and bioavailability. The
Automotive Lubricants Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
Automotive Lubricants Market Size Analysis, Competitive Insights, Leading Player …
Automotive Lubricants Market was valued at approximately USD 70.44 billion. By 2033, it is expected to reach around USD 107.09 billion, growing at a CAGR of about 3.3% from 2025 to 2033. Automotive Lubricants Market Overview The automotive lubricants market consists of products like engine oils, gear oils, greases, hydraulic fluids, and transmission fluids that reduce friction, wear and tear, and improve efficiency and lifespan of vehicle components. Demand is driven by

All 5 Releases


More Releases for Vaccine

Adult Vaccines Market By Type (Preventive Vaccine, Therapeutic Vaccine)
Global Adult Vaccines Market 2022 Research Report initially provides a basic overview of the industry that covers definition, applications and manufacturing technology, post which the report explores into the international players in the market. Download Sample PDF at  https://www.theinsightpartners.com/sample/TIPRE00007244/?utm_source=OpenPR&utm_medium=10379 Key Players Analysis:  AstraZeneca  Bharat Biotech  Dynavax Technologies Corporation  GlaxoSmithKline  Johnson & Johnson  Merck and Co  Novartis  Pfizer  Sanofi Pasteur  Serum Institute of India The report covers key developments in the Adult Vaccines market as organic and inorganic growth strategies. Various companies are focusing
Flu Vaccine (Influenza Vaccine) Market: A look into the future of the “Univers …
Latest update on Flu Vaccine (Influenza Vaccine) Market Analysis Report published with an SMI, the industry growth analysis, and Projection by 2021-2028. This report is highly predictive as it holds the overall market analysis of the topmost companies in the Flu Vaccine (Influenza Vaccine) industry. With the classified Flu Vaccine (Influenza Vaccine) market research based on various growing regions, this report provides leading players' portfolios along with sales, growth, market
Vaccine Market
Rise in the prevalence of infectious diseases, increase in immunization programs across the globe, and surge in R&D activities to develop new vaccine drive the growth of the global vaccine market. Global Vaccines Market was pegged at $32.46 billion in 2019, and is anticipated to hit $54.15 billion by 2027, registering a CAGR of 6.6% from 2020 to 2027. The report provides an in-depth analysis of the top investment pockets, top
US Flu Vaccine [Influenza Vaccine] Market Research Report 2020
DPI Research offers a latest published report on “Influenza Vaccines in the United States – Market Size, Trends, Opportunities and Growth Potential” delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key US flu vaccines market players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze
Measles Vaccine
Measles Vaccine Market describes its growth, size, share, Forecast and trends to 2025 Measles Vaccine Market Production and Demand Analysis 2019 to 2025 Measles Vaccine Market 2019 Manufacturing Analysis and Development Forecast 2025 Measles Vaccine Market 2019: Recent Study Including Growth Factors, Regional Drivers, Forecast 2025 Measles Vaccine Market to Insight By 2025: Top Key Vendors The global Measles Vaccine market is valued at million US$ in 2018 and will reach million US$ by the
Monovalent vaccine segment to accumulate maximum Paediatric Vaccine Market share
According to a new report published by Future Market Insights titled “Paediatric Vaccine Market: Global Industry Analysis & Opportunity Assessment, 2016 – 2026”, in terms of revenue, the global paediatric vaccine market is expected to increase at 12.2% CAGR during the forecast period 2016-2026. The global paediatric vaccine market is expected to reach US$ 27.97 Bn in 2016. Paediatric vaccine market is a billion dollar market accounting for a substantial proportion